Federal grant will be used to help company advance B cell technology
Dr. Jean Carruthers to Highlight Key Aesthetic Clinical Study Results for This Novel Neurotoxin with a Unique Clinical Profile.
SHINE-1 Results Suggest EB-001A May Improve Appearance of Scars.
Tissue repair is a prolonged process that lasts for at least six months after a severe muscle strain injury
The Company welcoms Dr. Boubakeur Belaroussi as Head of Product, Maartje Meijer as Head of Operations, Frank Cerrone as a lead MRI Technologist and Yeda Ford as a Head of Commercial Operations.